cover thank morning, XXXX. several results Good you joining as Today, quarter Thanks, including outlook well Simon. full topics, us. year for I'll and our for fourth our as all and XXXX
Slide X. begin on Let's
and billion, sales X.X%. of organic revenue quarter fourth reported representing growth was Our $X.XX sales of growth X.X%
$XX strong positively approximately basis points over in growth Foreign Prosthetics compared single-digit and in grew constant performance sales China million which quarter. or growth the business. our global and both quarter by high included aligners Implants & a year basis, XXX the XX%, to double-digit the in sales highlights impacted currency Wellspect key prior currency On in
to due Endo rate. within higher contracted the X% in product largely the basis lower-margin Adjusted sales year, down EBITDA by mix margins margins, declined to Despite tax XXX in largely XX to points. lower basis due which mainly This country sales, was EPS higher year-over-year margins quarter implant and China portfolios. a CAD/CAM from quarter, gross and $X.XX, was unfavorable decline in prior our points mix the and gross due in driven unfavorable
at operating management by average conversion generated repurchased In cash flow prior in an flow, $XXX the year. compared cash we of million million to $XXX XXX% fourth inventory price quarter, payable was stock improved year-over-year, and the accounts XXX% $XX prior timing $XX.XX we compared the of paid up million fourth In dividends. to XX% year. driven and the Free quarter, of the in of
the returned For full million to $XXX we year, shareholders.
and Essential Starting Solutions Resto Slide segment, sales segment and EDS which increases benefited from includes by performance each implemented in category. stable growth traffic product products, grew Let's in the X.X%, fourth in now Dental and earlier the turn with to preventive X patient quarter all price driven Organic year. on X. Endo regions
grew Solutions Orthodontic single the to Liners grew segment, and organic high sales digits. XX.X%. Shifting Implant
and from grew SureSmile continues differentiated benefit Specifically, new and outcomes. product to market gains, offerings share XX%
the believe of Additionally, sales. will future launch SureSmile Core our DS simulator we recent within benefit
Our constrained direct-to-consumer X% Byte financing environment. aligner a grew despite brand
planning, are XX% treatment in sales, With anticipated than growth interest, investment our our the and greater recent which we year. supports uptick this in in new Byte ramping support clinical customer
expect also digits double grow to SureSmile XXXX. We in
driven Moving quarter and to China and in Globally, Implants & premium share saw Prosthetics. in gains spot by Double-digit growth the VBP was and implants clear similar a in demand bright Europe. growth rates. value market higher
decline quarter saw showed in X.X% but down Our a anticipate of previous we organic up prior business less quarter. CTS, year to Solutions versus growth our declined U.S. a Connected in the quarters, performance, return dental Technology our XXXX. and than implants Wrapping slightly segment sales the was
double Instruments digits, single increased the low the quarter. digits in grew Our the in & global CAD/CAM declined while Equipment business by demand driven U.S. business
to Organic in sales and the Moving HealthCare. Wellspect Europe growth XX.X%, by grew U.S. driven
reminder, comp As quarter a had Italy. as Wellspect an in by was matter onetime a the pricing impacted prior easier year
In addition, year-over-year launches new contributed better-than-expected product growth. to
the historical distributor sequentially levels the low. essentially to CAD/CAM Now instruments discuss year end performance decreased averages, aligners U.S. the by $X XXXX. inventory implants in Relative of region. to by compared levels financial and distributor fourth U.S. Slide quarter X.X% strong sales in declined and equipment. flat to by let's turn growth lower quarter to ended inventory of approximately to CAD/CAM remain X partially sales and due equipment offset million
region to growth in France Wellspect, The EDS growth contributions with SureSmile Spain, in quarter returned from notable grew Europe. the to and Germany. XX% over Turning with OIS. and
higher new also DS an increase to We by XiVE, driven our OmniTaper in from demand implants in product, MIS legacy and implant. our growth saw conversions
which largest the lower continued segment recessionary in the market impacts, CTS particularly Our Germany, due region. in volumes to see to is
our base. Rest The on delivered a rebate compared continue In than equipment. to during quarter, declined experience sales Excluding China, XXXX, from led we growth. growth organic and prior by more in public increase government quarter quarter XX% to significant the grew prior year implants Japan of both saw the sales Europe the market significant organic in the benefited as in which year. Germany, sector programs private World grew in certain X.X% Sales China X.X% implants. customer
the SureSmile, of saw first regional the to countries Interoil we In driven by Latin Wrapping demand in performance. the within America ] Core half other quarter, plan region. digits scanner launch refurbished [ Mexico. up Brazil led in launch in and units sales DS and volume, We high the by execution solid Primescan the grew improvement region. Primeprint an single of Omnicam in and Connect sales Brazil in and QX and
and Sales let's billion, growth Now XXXX of growth representing sales briefly the for year reported turn sales X performance. X.X% year full to cover our of to full organic were Slide $X.XX X.X%.
in aligners dollar basis impacted offset implants, XXX due with significantly the Key included a currency to due higher currencies. than high by year more pricing points in growth growth and Foreign highlights major declines negatively sales the volume to translation most stronger associated primarily single-digit double-digit for China VBP. in versus which
we see in instruments, as well Germany competitive interest challenge and infrastructure, restructuring and largest partially volumes rates we we in margins and investments in to EBITDA equipment higher XX.X% markets and other attribute cost XXXX continuing concerns higher points organization was this lower due developed and the The offset to into as and by basis saw the XXX education contracted U.S., trend pressure commercial recessionary in benefits. inflation XXXX. which to clinical
the restructuring XX% our unfavorable million, and guidance cash conversion and XX% payable. and accounts by flow were investments, receivable $X.XX cash of accounts of down cash Operating of adjusted was to XX% Free EBITDA our with compared year-over-year, XXXX. higher $XXX timing range. was at driven line was margins outlays EPS flow in in midpoint
our a we with on November, cash in initiatives. transformation mentioned our Investor goal we recent free the flow consistent long-term Day to move outlays during associated XXX% past conversion achieve basis is cash once our As
and above continues million company double-digit of a ratio a dividend year sheet announced to with rate plan. hand, of X.Xx, is which quarter dividend. due the also a slightly balance our in of $XXX increase cash to and cash our Today, consecutive equivalents with and long-term make approximately finished marks net on debt-to-EBITDA The strong of share $XXX buyback. the million long-term to we our X.Xx fourth our increases fourth XX% confidence This demonstrates our the year to targeted
X to for Slide With let's to move expectations XXXX. our discuss that,
a to XXXX, expect to $X.XX organic we range represents up billion. flat of sales For billion which X.X% sales to $X.XX net be
the remain the slight to we expect based current year particularly anticipate FX a growth cautious headwind the to in for quarters, on organic for be and of reported on We the next rates stronger several half sales equipment. macroeconomic sales second backdrop as
points year-over-year. XXXX, in EBITDA of approximately XXX We XX% than margin be greater expect an our to basis expansion
We to savings. margin full in as the finalize due rate mix XXXX projected the an the as expect planning tax restructuring our full rate geographic tax than to also income higher timing initiatives. improvement investments We be we based year year increase our on of expect we through progress QX year and tax the and
range We expect be in adjusted of to earnings $X to the per share $X.XX.
sales see this, FX up million. trends. Wellspect comp sequential QX, by reported be expect $XX due is in headwind For the to with flat a we QX. in anticipated slightly be organic to OIS improve prior mid-single In expect CTS With QX, and EDS tougher growth we margin Healthcare, based EPS to will a expect to current year-over-year. on lower declines to to digits projected On and basis, sales offset we in due approximately year gross of roughly
XX XXXX to Slide to to at midpoint is Organic contribute outlook. turn EPS growth puts the in discuss earnings. and $X.XX adjusted takes expected our to the Let's
Our projected The and in SureSmile run restructuring expect investments, should cost for of XXXX expenses, plan this investments ERP $X.XX $XXX from rate we Net expansion. include approximately XXXX. savings the of the of will EPS. Byte reach contribute million
expect tailwind previous our a be with net to consistent We comments November Investor at EPS, hedges will our $X.XX investment Day.
drivers the over other Simon. items, versus I outlook forecasting are call to midpoint With back a turn EPS. $X.XX that up the double range, now to prior and We count combined of share net of tax that, digits These the cost namely to at headwind will $X.XX EPS adjusted year. the to inflation, will